SCHEMBL14036628

SCHEMBL14036628

CCc1cc(F)c(C=O)cc1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.34
TSHR P16473 1/20 0.34
ERN1 O75460 3/20 0.34
SMN1; SMN2 Q16637 1/20 0.33
NOS3 P29474 1/20 0.33
NOS1 P29475 1/20 0.33
NOS2 P35228 1/20 0.33
SRC P12931 1/20 0.33
GRIA1 P42261 1/20 0.32
GRIA2 P42262 1/20 0.32
GRIA3 P42263 1/20 0.32
GRIA4 P48058 1/20 0.32
POLB P06746 1/20 0.32
MAPT P10636 1/20 0.32
RAB9A P51151 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.31
MCL1 Q07820 1/20 0.31
LMNA P02545 1/20 0.31
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12375394 0.81 ALDH1A1 (0.41) ALDH1A1TSHRERN1SMN1; SMN2GRIA1
SCHEMBL365835 0.79 ALDH1A1 (0.39) ALDH1A1TSHRERN1SMN1; SMN2GRIA1
SCHEMBL20575666 0.78 LMNA (0.41) ALDH1A1ERN1POLBMAPTRAB9A
SCHEMBL12961324 0.78 MCL1 (0.34) ALDH1A1ERN1L3MBTL1MCL1LMNA
SCHEMBL13898962 0.78 NOS3 (0.40) ALDH1A1TSHRNOS3NOS1NOS2
SCHEMBL14036539 0.77 GRIA1 (0.44) ALDH1A1TSHRERN1SMN1; SMN2NOS3
SCHEMBL5504159 0.76 ALDH1A1 (0.41) ALDH1A1TSHRERN1SMN1; SMN2GRIA1
SCHEMBL15250021 0.76 NOS3 (0.39) ALDH1A1TSHRNOS3NOS1NOS2
SCHEMBL20022271 0.76 ALDH1A1 (0.50) ALDH1A1TSHRERN1POLBMAPT
SCHEMBL248719 0.75 ERN1 (0.50) ALDH1A1TSHRERN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008137102-A2 METHODS OF MODULATING AMYLOID BETA AND COMPOUNDS USEFUL THEREFOR TORREYPINES THERAPEUTICS, INC. (US) 2008-11-13 WO disclosed